Logo image of SAGT

SAGTEC GLOBAL LTD (SAGT) Stock Fundamental Analysis

NASDAQ:SAGT - Nasdaq - VGG7779D1087 - Common Stock - Currency: USD

2.69  +0.15 (+5.91%)

Fundamental Rating

5

Overall SAGT gets a fundamental rating of 5 out of 10. We evaluated SAGT against 284 industry peers in the Software industry. SAGT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SAGT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year SAGT was profitable.
SAGT had a positive operating cash flow in the past year.
SAGT Yearly Net Income VS EBIT VS OCF VS FCFSAGT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 25.32%, SAGT belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
SAGT has a Return On Equity of 41.25%. This is amongst the best in the industry. SAGT outperforms 94.01% of its industry peers.
SAGT has a Return On Invested Capital of 34.38%. This is amongst the best in the industry. SAGT outperforms 97.18% of its industry peers.
SAGT had an Average Return On Invested Capital over the past 3 years of 29.05%. This is significantly above the industry average of 12.36%.
The 3 year average ROIC (29.05%) for SAGT is below the current ROIC(34.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 25.32%
ROE 41.25%
ROIC 34.38%
ROA(3y)21.86%
ROA(5y)N/A
ROE(3y)41.06%
ROE(5y)N/A
ROIC(3y)29.05%
ROIC(5y)N/A
SAGT Yearly ROA, ROE, ROICSAGT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30 40

1.3 Margins

With a decent Profit Margin value of 13.32%, SAGT is doing good in the industry, outperforming 79.23% of the companies in the same industry.
SAGT has a Operating Margin of 18.25%. This is amongst the best in the industry. SAGT outperforms 86.27% of its industry peers.
SAGT's Gross Margin of 23.38% is on the low side compared to the rest of the industry. SAGT is outperformed by 80.28% of its industry peers.
Industry RankSector Rank
OM 18.25%
PM (TTM) 13.32%
GM 23.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SAGT Yearly Profit, Operating, Gross MarginsSAGT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

SAGT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SAGT has about the same amount of shares outstanding.
SAGT has a better debt/assets ratio than last year.
SAGT Yearly Shares OutstandingSAGT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
SAGT Yearly Total Debt VS Total AssetsSAGT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 11.82 indicates that SAGT is not in any danger for bankruptcy at the moment.
SAGT has a better Altman-Z score (11.82) than 87.68% of its industry peers.
The Debt to FCF ratio of SAGT is 4.06, which is a neutral value as it means it would take SAGT, 4.06 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.06, SAGT is in the better half of the industry, outperforming 61.27% of the companies in the same industry.
SAGT has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
SAGT's Debt to Equity ratio of 0.16 is in line compared to the rest of the industry. SAGT outperforms 48.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 4.06
Altman-Z 11.82
ROIC/WACC3.98
WACC8.64%
SAGT Yearly LT Debt VS Equity VS FCFSAGT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

SAGT has a Current Ratio of 2.01. This indicates that SAGT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.01, SAGT is in the better half of the industry, outperforming 61.62% of the companies in the same industry.
A Quick Ratio of 2.01 indicates that SAGT has no problem at all paying its short term obligations.
SAGT has a better Quick ratio (2.01) than 61.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 2.01
SAGT Yearly Current Assets VS Current LiabilitesSAGT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.72% over the past year.
SAGT shows a strong growth in Revenue. In the last year, the Revenue has grown by 77.59%.
EPS 1Y (TTM)54.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.72%
Revenue 1Y (TTM)77.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SAGT Yearly Revenue VS EstimatesSAGT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.69, the valuation of SAGT can be described as rather expensive.
Based on the Price/Earnings ratio, SAGT is valued cheaper than 80.63% of the companies in the same industry.
SAGT is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.69
Fwd PE N/A
SAGT Price Earnings VS Forward Price EarningsSAGT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SAGT indicates a rather cheap valuation: SAGT is cheaper than 88.73% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAGT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 164.74
EV/EBITDA 12.31
SAGT Per share dataSAGT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

The decent profitability rating of SAGT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SAGT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAGTEC GLOBAL LTD

NASDAQ:SAGT (6/18/2025, 5:33:14 PM)

2.69

+0.15 (+5.91%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.11%
Inst Owner ChangeN/A
Ins Owners69.38%
Ins Owner ChangeN/A
Market Cap33.76M
AnalystsN/A
Price TargetN/A
Short Float %1.6%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.69
Fwd PE N/A
P/S 2.76
P/FCF 164.74
P/OCF 24.86
P/B 8.54
P/tB 8.54
EV/EBITDA 12.31
EPS(TTM)0.13
EY4.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.61%
OCF(TTM)0.11
OCFY4.02%
SpS0.98
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 25.32%
ROE 41.25%
ROCE 45.34%
ROIC 34.38%
ROICexc 35.18%
ROICexgc 35.18%
OM 18.25%
PM (TTM) 13.32%
GM 23.38%
FCFM 1.67%
ROA(3y)21.86%
ROA(5y)N/A
ROE(3y)41.06%
ROE(5y)N/A
ROIC(3y)29.05%
ROIC(5y)N/A
ROICexc(3y)30.07%
ROICexc(5y)N/A
ROICexgc(3y)30.07%
ROICexgc(5y)N/A
ROCE(3y)40.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 4.06
Debt/EBITDA 0.24
Cap/Depr 280.77%
Cap/Sales 9.41%
Interest Coverage 36.19
Cash Conversion 51.32%
Profit Quality 12.56%
Current Ratio 2.01
Quick Ratio 2.01
Altman-Z 11.82
F-Score6
WACC8.64%
ROIC/WACC3.98
Cap/Depr(3y)309.92%
Cap/Depr(5y)N/A
Cap/Sales(3y)21.55%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)77.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y74.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y128.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.41%
OCF growth 3YN/A
OCF growth 5YN/A